TG Therapeutics Raises Fiscal 2026 Revenue Guidance on Nov. 9
TG Therapeutics now expects fiscal 2026 revenue of about $1.0 billion, up from about $950 million. Related Stocks: TGTX ,
TG Therapeutics now expects fiscal 2026 revenue of about $1.0 billion, up from about $950 million. Related Stocks: TGTX ,